Amanta Healthcare
Ticker > Company >

Amanta Healthcare share price

Amanta Healthcare Ltd.

  10.84 K   3   1 NSE: AMANTA BSE: 544502 SECTOR: Pharmaceuticals & Drugs

185.90
+3.60 (1.97%)
BSE: 29 Sep 04:01 PM

Buy on Angel One

Price Summary

Today's High

₹ 185.9

Today's Low

₹ 180

52 Week High

₹ 206.65

52 Week Low

₹ 93.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 721.84 Cr.

Enterprise Value

₹ 863.62 Cr.

No. of Shares

3.88 Cr.

P/E

49.19

P/B

3.23

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  57.56

CASH

₹ 92.64 Cr.

DEBT

₹ 234.42 Cr.

Promoter Holding

63.8 %

EPS (TTM)

₹  3.78

Sales Growth

4.72%

ROE

9.4 %

ROCE

11.23%

Profit Growth

41.66 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.72%
3 Year3.55%
5 Year10.93%

Profit Growth

1 Year41.66%
3 Year108.38%
5 Year21.81%

ROE%

1 Year9.4%
3 Year9.31%
5 Year34.76%

ROCE %

1 Year11.23%
3 Year13.52%
5 Year18.8%

Debt/Equity

1.0645

Price to Cash Flow

14.9

Interest Cover Ratio

2.0183

CFO/PAT (5 Yr. Avg.)

3.20937432687713

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 63.80 0.00
Mar 2026 63.72 0.00
Dec 2025 63.56 0.00
Sep 2025 63.56 0.00
Jun 2025 63.56 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 108.376396333113% for the Past 3 years.
  • The Company has been maintaining an effective average operating margins of 21.00758% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -60.8402 days.
  • The company has a good cash flow management; CFO/PAT stands at 3.20937432687713.
  • The company has a high promoter holding of 63.8%.

 Limitations

  • The company has shown a poor revenue growth of 3.54502504425738% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 65.31 70.89 74.49 77 68.8
Total Expenditure 50.41 56.24 59.13 62.04 54.26
Operating Profit 14.89 14.65 15.36 14.95 14.54
Other Income 0.96 0.07 0.68 1.66 0.64
Interest 6.29 5.15 5.06 4.25 6.01
Depreciation 4.64 4.66 4.67 4.75 4.69
Exceptional Items 0 -2.63 0 0 0
Profit Before Tax 4.93 2.28 6.3 7.62 4.49
Tax 1.42 1.07 1.68 2.09 1.18
Profit After Tax 3.51 1.21 4.63 5.53 3.31
Adjusted EPS (Rs) 1.22 0.35 1.35 1.61 0.85

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 225.44 259.13 280.34 274.71 287.68
Total Expenditure 171.81 208.23 222.85 215.04 227.82
Operating Profit 53.63 50.9 57.49 59.67 59.86
Other Income 0.83 5.41 1.27 1.39 3.37
Interest 43.91 35.27 33.64 27.95 20.75
Depreciation 17.28 18.35 19.73 18.4 18.73
Exceptional Items 68.52 0 0 0 -2.63
Profit Before Tax 61.79 2.69 5.39 14.71 21.12
Tax 7.91 4.8 1.76 4.21 6.25
Net Profit 53.88 -2.11 3.63 10.5 14.88
Adjusted EPS (Rs.) 20.08 -0.79 1.35 3.64 3.83

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 26.83 26.83 26.83 28.83 38.83
Total Reserves 38.14 36.05 39.46 67.56 181.38
Borrowings 175.91 175.55 149.03 132.36 161.97
Other N/C liabilities 26.85 38.49 35.14 56.36 34.74
Current liabilities 111.72 97.26 104.74 117.73 147
Total Liabilities 379.46 374.19 355.2 402.84 563.92
Assets
Net Block 241.33 237.68 228.15 217.14 207.18
Capital WIP 0 0 0 6.55 81.52
Intangible WIP 0 0 0 0 0
Investments 3.34 3.47 3.72 7.72 7.05
Loans & Advances 2.24 1.87 2.23 30.86 16.09
Other N/C Assets 0.04 0.04 0.13 0 7.62
Current Assets 132.51 131.14 120.97 140.57 244.47
Total Assets 379.46 374.19 355.2 402.84 563.92
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 61.79 2.69 5.39 14.71 21.12
Adjustment -6.89 53.53 53.66 46.76 40.78
Changes in Assets & Liabilities 8.73 -7.33 4.97 -11.05 -6.4
Tax Paid -0.1 -6.31 -5.95 -3.8 -7.06
Operating Cash Flow 63.53 42.58 58.07 46.62 48.45
Investing Cash Flow -5.38 -6.53 -10.32 -24.47 -93.61
Financing Cash Flow -51.99 -42.32 -46.32 -23.47 125.95
Net Cash Flow 6.17 -6.27 1.43 -1.32 80.79

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research BP Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Amanta Healthcare Stock Price Analysis and Quick Research Report. Is Amanta Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Amanta Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Amanta Healthcare has a PE ratio of 49.3861784315801 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Amanta Healthcare has ROA of 3.0773% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Amanta Healthcare has a Current ratio of 1.6631.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Amanta Healthcare has a ROE of 9.3969%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Amanta Healthcare has a Debt to Equity ratio of 1.0645 which means that the company has low proportion of debt in its capital.

  • Sales growth: Amanta Healthcare has reported revenue growth of 4.7208% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Amanta Healthcare for the current financial year is 20.8075593191941%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Amanta Healthcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Amanta Healthcare is Rs 3.7796. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Amanta Healthcare in Ticker for free. Also, one can get the intrinsic value of Amanta Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Amanta Healthcare FAQs

Q1. What is Amanta Healthcare share price today?
Ans: The current share price of Amanta Healthcare is Rs 186.66.

Q2. What is the market capitalisation of Amanta Healthcare?
Ans: Amanta Healthcare has a market capitalisation of Rs 724.788665766 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Amanta Healthcare?
Ans: The PE ratio of Amanta Healthcare is 49.3861784315801 and the P/B ratio of Amanta Healthcare is 3.24260095995998, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Amanta Healthcare share?
Ans: The 52-week high share price of Amanta Healthcare is Rs 209.95, and the 52-week low share price of Amanta Healthcare is Rs 92.

Q5. Does Amanta Healthcare pay dividends?
Ans: Currently, Amanta Healthcare does not pay dividends. Dividend yield of Amanta Healthcare is around 0%.

Q6. What are the face value and book value of Amanta Healthcare shares?
Ans: The face value of Amanta Healthcare shares is Rs 10, while the book value per share of Amanta Healthcare is around Rs 57.5649. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Amanta Healthcare?
Ans: Amanta Healthcare has a total debt of Rs 234.4181 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Amanta Healthcare?
Ans: The ROE of Amanta Healthcare is 9.3969% and ROCE of Amanta Healthcare is 11.2251%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Amanta Healthcare a good buy for the long term?
Ans: The Amanta Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Amanta Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Amanta Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Amanta Healthcare’s financials?
Ans: You can review Amanta Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Amanta Healthcare

Amanta Healthcare Share Price, Business Overview & Latest News

Amanta Healthcare made a strong stock market debut on September 9, 2025, with its shares listing at a premium to the IPO price. The Amanta Healthcare share price opened at Rs 135 on the NSE, a 7.14% premium, and Rs 134 on the BSE, a 6.35% premium, compared to the issue price of Rs 126. The stock quickly gained momentum, reaching an intraday high of Rs 141.75, a 12.5% increase from its IPO price, indicating robust investor interest.

About Amanta Healthcare Ltd.

Founded in 1994, Amanta Healthcare is a pharmaceutical company based in Ahmedabad, specializing in sterile liquid formulations. The company develops, manufactures, and markets a diverse range of parenteral products, including IV fluids, ophthalmic solutions, and respiratory care products, using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. Amanta Healthcare also produces medical devices such as irrigation solutions and eye lubricants. The company has a significant domestic presence with a network of approximately 320 stockists and a growing export footprint in 21 countries.

Amanta Healthcare Share Price and Listing Day Performance

  • Listing Price (NSE): Rs 135 per share (7.14% premium)

  • Listing Price (BSE): Rs 134 per share (6.35% premium)

  • Intraday High: Rs 141.75 per share

  • Market Capitalisation: Approximately Rs 550 crore

  • IPO Subscription: The IPO was oversubscribed 82.60 times, highlighting strong demand from all investor categories.

Key Financial Highlights

For the fiscal year ending March 2025, Amanta Healthcare reported:

  • Revenue: Rs 276.1 crore

  • Profit After Tax (PAT): Rs 10.5 crore (a 189% increase from the previous year)

  • EBITDA: Rs 61 crore, with a margin of 22.1%

Despite the impressive profit growth, some analysts noted that the IPO was "fully priced," with a P/E ratio of nearly 47x based on FY25 earnings, suggesting limited room for immediate upside.

What You Can Find on This Company Page

This page provides a comprehensive overview of Amanta Healthcare Ltd., designed to keep investors informed with the latest data and insights. Here’s what you can access:

  • Live Share Price and Interactive Charts: Track the Amanta Healthcare share price in real-time and analyse its performance since listing with dynamic charts.

  • IPO and Listing Details: Get all the information about the IPO, including the price band, subscription details, and listing day performance.

  • Financial Statements: Access detailed financial data, including Profit & Loss statements, Balance Sheets, and Cash Flow analysis to evaluate the company's financial health.

  • Key Ratios and Valuations: Review important metrics like the P/E ratio, P/B ratio, and dividend yield to assess the stock's valuation.

  • Peer Comparison: Compare Amanta Healthcare's performance with other companies in the pharmaceutical sector, such as Sun Pharma, Divi's Labs, and Cipla.

  • Corporate Actions and News: Stay updated on company announcements, including dividends, board meetings, and other corporate actions.

Frequently Asked Questions (FAQs) about Amanta Healthcare Share Price

Q1: What was the listing price of Amanta Healthcare?
The shares listed at Rs 135 on the NSE and Rs 134 on the BSE on September 9, 2025, marking a premium of over 6-7% against the issue price of Rs 126.

Q2: How did the stock perform on its listing day?
The stock saw strong buying interest, rising to an intraday high of Rs 141.75, a 12.5% gain from its IPO price.

Q3: How was the IPO received by investors?
The IPO was heavily oversubscribed, with an overall subscription of 82.60 times, indicating robust demand across all investor categories.

Q4: What are the future plans for Amanta Healthcare?
The company plans to use the IPO proceeds to fund expansion, including setting up a new SteriPort manufacturing line and another line for small-volume parenterals (SVPs) at its facility in Gujarat.

Q5: What are the key financial metrics for Amanta Healthcare?
For FY25, the company reported revenue of Rs 276.1 crore and a net profit of Rs 10.5 crore, with an EBITDA margin of 22.1%.

For the most current updates on the Amanta Healthcare share price, financial news, and market analysis, refer to the regularly updated tools and data provided on this page.

Read More
X